Cited by 248Advanced Drug Delivery SystemsNanoparticle-Based Drug DeliveryDrug Solubulity and Delivery Systems

Advances in colon-targeted nano-drug delivery systems: challenges and solutions

Naeem, Muhammad, Awan, Uzma Azeem, Subhan, Fazli, Cao, Jiafu, Hlaing, Shwe Phyu, Lee, Juho, Im, Eunok, Jung, Yunjin +1 more·2020·Archives of Pharmacal Research

Abstract

Nano-drug delivery systems (NDDS) for colon-targeted drug delivery are an active area of research on local diseases affecting the colon, such as ulcerative colitis, Crohn's disease, colon cancer, and for the delivery of peptide or protein drugs and vaccinations. In particular, targeted nano-drug delivery to the colon is advantageous for colon-specific diseases because nanoparticles can accumulate in diseased parts, improve the efficacies of therapeutics, and enable localized treatments, which reduces systemic toxicity. However, there are many hurdles, such as burst drug release, enzyme and acidic degradation of drug and carrier in the stomach, pH variations, mucus entrapment, and systemic uptake in the upper small intestine, which could challenge and compromise the successful delivery of NDDS to the colon. With advancements in NDDS, it may be possible to overcome these challenges leading to efficient drug delivery for colon-specific disorders. This review describes a few of the potential colon-specific drug delivery areas and the challenges faced by colon-targeted orally administered delivery systems, and provides an updated summary of recent advances in the development of orally administered NDDS for colon targeting, and the future advances in this research.

Integrity signals

Registry

Crossref · 10.1007/s12272-020-01219-0

Cites

138 of 138 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Colonic drug delivery is beneficial for treating arthritis, angina, nocturnal asthma, and colonic disorders such as colorectal cancer, Crohn's disease, and ulcerative colitis.

    “Colonic drug delivery is beneficial for treating arthritis, angina, nocturnal asthma, and colonic disorders such as colorectal cancer, Crohn’s disease, and ulcerative colitis (Arévalo-Pérez et al., 2020; Lee et al., 2020; Naeem et al., 2020; Cui et al., 2021).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Naeem, M., Awan, U. A., Subhan, F., Cao, J., Hlaing, S. P., Lee, J., Im, E., Jung, Y., & Yoo, J.-W.
Affiliations
  • National University of Medical Sciences (PK)
  • Pusan National University (KR)
Corresponding author
Yoo, Jin-Wook
Venue
Archives of Pharmacal Research
Published
2020-01
Volume
43
Issue
1
Pages
153-169
ISSN
  • 0253-6269 (ISSN-L)
  • 1976-3786
OpenAlex
W3000884526
Cited by
248
References
138
Citations by year
2026: 22 · 2025: 57 · 2024: 44 · 2023: 50 · 2022: 40 · 2021: 20 · 2020: 14
FWCI
2.70
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Pharmacal Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
Ministry of Education (NRF-2019R1I1A3A01057849)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
Keywords
colon-targeted drug delivery, nanoparticle drug delivery, oral drug delivery, gastrointestinal pH, enzyme degradation, ulcerative colitis, Crohn's disease, colon cancer
MeSH terms
Animals, Colonic Diseases, Drug Carriers, Humans, Hydrogen-Ion Concentration, Drug Delivery Systems, Nanoparticles, Drug Liberation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review